Protecting America’s Crumbling Bridges with Galvanized Rebar

 

It’s no secret that America has a crumbling infrastructure problem, notably when it comes to our nation’s bridges which are reaching the end of their useful life. Many of these structures were built to last only a few decades, but are now aging past the half-century mark and beyond. So why were they not constructed with longevity in mind?

On this episode of the Engineering & Construction podcast, Mike Stroia, national marketing specialist at AZZ GalvaBar, shared some infrastructure history and how galvanized rebar can help safeguard bridges against collapse.

“The majority of bridges in the U.S. and throughout the world don’t have any kind of protection whatsoever,” Stroia said.

He estimated that only 20% have some form of coating that can act as a shield against harmful corrosion. Galvanizing applies a zinc coating that reinforces rebar steel to give it unbeatable durability. However, rebar doesn’t easily lend itself to galvanizing.

As Stroia explained, galvanizing is a costly process that requires a lot of man-hours and handling. Faced with the added expense, short-sighted governments and private owners simply weren’t keen on investing in long-lasting products. But it seems like all that penny pinching has a price of its own.

“The most costly is the deck structure, and once that begins to fail there’s not a lot of time left in the bridge,” Stroia said.

The good news is that mindsets are starting to change.

“We think the marketplace is turning the corner on using corrosion-resistant products,” he said.

Those writing checks for new toll roads, parking structures, and bridges finally understand that paying a little more money upfront can buy a lifetime of protection.

Stroia also reminded listeners that AZZ GalvaBar is partnering with Texas A&M and the International Zinc Association to put on a seminar on August 28 which includes a live webinar and an in-person event. He invited interested community members to come and tour the university’s impressive engineering facility at College Station and hear his presentation on the future of galvanized rebar.

For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @AECMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More